Stock Quote Colgate Palmolive: Complete Guide to Investing and Trading

Colgate Palmolive is a multinational consumer goods company with a rich history dating back to 1806.

The company's stock symbol is CL, and it's listed on the New York Stock Exchange (NYSE).

Colgate Palmolive is a household name with a diverse portfolio of brands, including Colgate toothpaste, Palmolive soap, and Softsoap body wash.

Its products are sold in over 200 countries worldwide, making it a truly global company.

The company has a market capitalization of over $70 billion, indicating its significant size and influence in the market.

Colgate-Palmolive Company's revenue was $19.46 billion in 2023, a 8.29% increase from the previous year. This growth is a testament to the company's strong financial performance.

The company's gross profit margin was 28.54% in 2023, a significant improvement from 25.74% in 2022. This increase in profitability is a result of Colgate-Palmolive's efforts to optimize its operations and improve its product offerings.

Here's a breakdown of the company's financial performance over the past few years:

The company's analysts expect its revenue to continue growing, with an estimated 12.52% increase in 2025, reaching $21,174 million. This growth is expected to be driven by the company's strong brand portfolio and its ability to innovate and adapt to changing market trends.

Ratios are a crucial aspect of financial analysis, and they can give us a clear picture of a company's performance. We can see this in the data from 2024, where the gross profit margin was a healthy 32.58%.

The net profit margin, on the other hand, tells us how much of the revenue is actually making it to the bottom line. In 2024, the net profit margin was 15.27%, which is a significant improvement from 2023's 11.38%.

EPS growth is another important ratio that shows us how much the earnings per share have increased over time. In 2024, the EPS growth was a whopping 66.11%, which is a clear sign of a company's financial health.

The PEG ratio gives us an idea of how the company's price compares to its earnings growth. A lower PEG ratio is generally better, and in 2024, the PEG ratio was a relatively low 0.26.

Here's a summary of the key ratios from 2024:

It's worth noting that the PEG ratio was even lower in 2023, at 0.34, which suggests that the company's stock price may have been undervalued at the time.

Colgate-Palmolive's revenue in 2023 was $19.46 billion, an 8.29% increase from the previous year.

The company's earnings in 2023 were $2.30 billion, a 28.85% increase from the previous year.

Colgate-Palmolive's revenue is projected to continue growing, with estimates for 2025, 2026, 2027, and 2028 ranging from $20.33 billion to $22.51 billion.

The company's dividend yield is expected to remain relatively stable, ranging from 2.29% to 2.45% over the next few years.

Here's a breakdown of Colgate-Palmolive's estimated revenue and earnings per share (EPS) for the next few years:

Colgate-Palmolive's estimated EPS growth rate is expected to be around 66.11% in 2024, followed by a 77.26% growth rate in 2023.

If this caught your attention, see: What Does the Fed Rate Cut Mean for Mortgage Rates

Colgate-Palmolive's Q3 earnings didn't quite meet expectations, with a 3% stock drop following the release.

The company's revenue and EPS beat estimates, which is a positive sign. However, this wasn't enough to offset declining sales in North America and Latin America.

Declining sales in these regions weighed heavily on the company's overall performance.